CLINICAL_TRIALS
trial_result
· 2018-11-08
Clinical Trial Update: Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis [Phase 3]
Summary
Phase 3 trial update reporting efficacy and safety of romosozumab in postmenopausal osteoporosis; results completed and posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Postmenopausal Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2018-11-08